Market Overview

UPDATE: JP Morgan Cuts PT to $70 on Vitamin Shoppe, Maintains Overweight on Intact Thesis

Share:
Related VSI
Are GNC, Vitamin Shoppe At Risk For A Health Scandal?
Books-A-Million, HomeAway, Vaalco Energy Lead Monday's After-Hours Movers
Revisiting The Vitamin Shoppe Story Featuring An Activist Investor (Seeking Alpha)

JP Morgan maintained Vitamin Shoppe (NYSE: VSI) with an Overweight and lowered the price target from $73.00 to $70.00.

JP Morgan commented, "[O]rganic store growth was ratcheted back down to 8.5% from 10% only five months after being ratcheted up, and VSI cited slight slippage in its 2013 private label product acceleration (after speaking quite optimistically just a month ago). Combined with the shift in tone from ICR, we believe investors either felt misled or questioned the degree of items on management's plate. Indeed, the dramatic sell off in the stock seemed to carry some anger with it today. Realistically, we expected it to be down but not even half the 18% drop experienced following earnings."

Vitamin Shoppe closed at $51.44 on Tuesday.

Latest Ratings for VSI

DateFirmActionFromTo
Feb 2015JefferiesMaintainsHold
Feb 2015BarclaysDowngradesOverweightEqual-weight
Nov 2014Goldman SachsDowngradesBuyNeutral

View More Analyst Ratings for VSI
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Analyst Ratings

 

Related Articles (VSI)

Around the Web, We're Loving...